Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y
- Status
- COMPLETED
- Phase
- PHASE3
Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children
- Status
- COMPLETED
- Phase
- PHASE3
A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Blood Levels of Itraconazole During a Two-Week Period
- Status
- COMPLETED
- Phase
- PHASE1
Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677
- Status
- COMPLETED
- Phase
- PHASE1
Study of Fish Oil to Reduce ALT Levels in Adolescents
- Status
- TERMINATED
- Phase
- PHASE1
Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women
- Status
- COMPLETED
- Phase
- PHASE2
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies
- Status
- COMPLETED
- Phase
- PHASE3